Skip to main content

Table 1 Description of the socio-demographic information (gender, age, occupation and duration of residence) of study participants

From: Prevalence of epilepsy in the onchocerciasis endemic middle belt of Ghana after 27 years of mass drug administration with ivermectin

Village

Proportion of village residents recruited for the study, % (n/N)e

Gender, % (n/N)

Median age

(IQR), years

Main occupation (farming), % (n/N)

Duration of residence in the community (≥ 15 years), % (n/N)

Females

Males

Tain District

      

 Abekwai 2a

48.0% (72/150)

40.3% (29/72)

59.7% (43/72)

19 (11.0‒36.3)

100% (72/72)

47.2% (34/72)

 Abekwai 3a

26.3% (184/700)

46.2% (85/184)

53.8% (99/184)

24 (15.0‒39.3)

100% (184/184)

59.2% (109/184)

 Attakromb

14.1% (113/800)

56.6% (64/113)

43.4% (49/113)

30 (20.0‒45.8)

95.6% (108/113)

42.5% (48/113)

 Kokombac

59.2% (71/120)

46.5% (33/71)

53.5% (38/71)

23 (13.0‒38.0)

100% (71/71)

19.7% (14/71)

Wenchi Municipality

      

 Blibord

23.8% (57/240)

38.6% (22/57)

61.4% (35/57)

23 (15.0‒35.0)

100% (57/57)

42.1% (24/57)

 Johnykrom

33.5% (57/170)

36.6% (26/57)

54.4% (31/57)

25 (11.0‒40.0)

94.7% (54/57)

64.9% (37/57)

 Subinso 1

7.1% (107/1500)

65.5% (72/107)

33.6% (35/107)

27 (14.3‒44.8)

73.8% (79/107)

71.0% (76/107)

 Subinso 2

4.7% (259/5500)

55.0% (142/258)

45.0% (117/258)

30 (18.0‒48.0)

68.7% (178/259)

59.5% (154/259)

 Kwanware

34.0% (51/150)

52.9% (27/51)

47.1% (24/51)

26 (9.5‒44.0)

98.0% (50/51)

84.3% (43/51)

Total

10.4% (971/9300)

51.4% (500/971)

48.6% (471/971)

25.2 (9.5‒48.0)

87.8% (853/971)

55.5% (539/971)

  1. aAlso spelled as Abekwae
  2. bAlso recorded as Atta-krom
  3. cAlso spelled as Konkomba
  4. dAlso recorded as Brilboe
  5. eThe denominators (N) are an approximation provided by the community drug distributors (CDDs) at the time of the study, and do not exactly correspond to the total population sizes reported in the therapeutic coverage records (Additional file 3: Tables S1 and S2)